Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tamoxifen and the uterus.

Authors: P Neven; X De Muylder; Y Van Belle; G Vanderick; E De Muylder
Journal: Eur J Obstet Gynecol Reprod Biol Date: 1990 May-Jun Impact factor: 2.435

7. Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation.

Authors: C A Hulka; D A Hall
Journal: AJR Am J Roentgenol Date: 1993-04 Impact factor: 3.959

8. Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen.

Authors: I Cohen; D J Rosen; R Tepper; M Cordoba; Y Shapira; M M Altaras; D Yigael; Y Beyth
Journal: J Ultrasound Med Date: 1993-05 Impact factor: 2.153

9. Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen.

Authors: S R Goldstein
Journal: Am J Obstet Gynecol Date: 1994-02 Impact factor: 8.661

10. Risk of endometrial cancer after tamoxifen treatment of breast cancer.

Authors: F E van Leeuwen; J Benraadt; J W Coebergh; L A Kiemeney; C H Gimbrère; R Otter; L J Schouten; R A Damhuis; M Bontenbal; F W Diepenhorst
Journal: Lancet Date: 1994-02-19 Impact factor: 79.321

5 in total

Review 1. The demise of the D&C.

Authors: C J Seamark
Journal: J R Soc Med Date: 1998-02 Impact factor: 5.344

5. Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment.

Authors: S Ciatto; S Cecchini; G Gervasi; A Landini; M Zappa; E Crocetti
Journal: Br J Cancer Date: 2003-04-22 Impact factor: 7.640

5 in total

Tamoxifen and the uterus.

1. Side effects of adjuvant tamoxifen.

2. Tamoxifen and the uterus and endometrium.

3. Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First report. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group.

4. Endometrial lesions in patients undergoing tamoxifen therapy.

5. Pathology of endometrium treated with tamoxifen.

6. Hysteroscopic follow-up during tamoxifen treatment.